Drug labeling/SPL for the USA

Your Speakers:

Dr. Susanne Becker: spm² - safety projects & more GmbH, Mannheim, GERMANY
Link: www.spm2-safety.de

Close
Kimberly K. Egan: DLA Piper US LLP, Washington, THE UNITED STATES
Close
Charles Mathis: LORENZ Life Sciences Group, THE UNITED STATES
Close
Martin Sujatta: spm² - safety projects & more GmbH, Mannheim, GERMANY
Close

Register

Your Contact: Dr. Henriette Wolf-Klein
Bereichsleiterin Pharma
E-Mail

Close

Venue:

Frankfurt: nH Frankfurt City
Vilbeler Straße 2
60313 Frankfurt

Tel. +49 69 928859-0
Fax +49 69 928859-100
www.nh-hotels.com
(new window)

Close

Fee:

890,- EUR zzgl. MwSt.

Further Information

Aims and Objectives: This seminar addresses the content,
structure and transfer of an SPL to
the US FDA:
Which are the essential types of
pharmaceutical and safety information
to be enclosed?
How is the SPL to be developed?
How are changes in the SPL to be
made and communicated?

Three experts from the US and Germany will
give you practical tips for your business.

Please note that this seminar also discusses
the hot topic of liability with regard to drug
labeling.

Close